A Nationwide Study of Severe Cutaneous Adverse Reactions Based on the Multicenter Registry in Korea

Medicine and Dentistry

• Drug Hypersensitivity 100%
• Adverse Event 80%
• Chemotherapeutic Agent 50%
• Eosinophilia 50%
• Drug 50%
• STEVENS-JOHNSON SYNDROME 50%
• Toxic Epidermal Necrolysis 50%
• Symptom 50%
• Tuberculostatic Agent 30%
• Vancomycin 20%
• Mortality Rate 20%
• Allopurinol 20%
• Carbamazepine 20%
• Phenotype 10%
• Nonsteroid Antiinflammatory Agent 10%
• Morbidity 10%
• Antiinfective Agent 10%
• Glycopeptide 10%
• Paracetamol 10%
• Causality 10%
• Skin Manifestation 10%
• Dapsone 10%
• Patient Referral 10%
• Carbonate Dehydratase Inhibitor 10%
• Mortality 10%
• Hospital 10%
• Medical Record 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 80%
• Eosinophilia 50%
• Drug 50%
• Toxic Epidermal Necrolysis 50%
• Stevens Johnson Syndrome 50%
• Symptom 50%
• Tuberculostatic Agent 30%
• Death 30%
• Vancomycin 20%
• Mortality Rate 20%
• Carbamazepine 20%
• Allopurinol 20%
• Antiinfective Agent 10%
• Glycopeptide 10%
• Paracetamol 10%
• Morbidity 10%
• Dapsone 10%
• Skin Manifestation 10%
• Causality 10%
• Carbonate Dehydratase Inhibitor 10%
• Mortality 10%

Immunology and Microbiology

• Stevens Johnson Syndrome 50%
• Mortality Rate 20%
• Allopurinol 20%
• Phenotype 10%
• Morbidity 10%
• Medical Record 10%
• Time 10%
• Mortality 10%
• Skin 10%